Free Trial

Quipt Home Medical (QIPT) Competitors

Quipt Home Medical logo
$2.15 +0.03 (+1.42%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$2.15 +0.00 (+0.23%)
As of 08/22/2025 05:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

QIPT vs. TOI, LFMD, VMD, XGN, DCGO, CORBF, NAKA, EUDA, SERA, and KDLY

Should you be buying Quipt Home Medical stock or one of its competitors? The main competitors of Quipt Home Medical include Oncology Institute (TOI), LifeMD (LFMD), Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), Global Cord Blood (CORBF), KindlyMD (NAKA), EUDA Health (EUDA), Sera Prognostics (SERA), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry.

Quipt Home Medical vs. Its Competitors

Quipt Home Medical (NASDAQ:QIPT) and Oncology Institute (NASDAQ:TOI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation.

42.9% of Quipt Home Medical shares are owned by institutional investors. Comparatively, 36.9% of Oncology Institute shares are owned by institutional investors. 13.4% of Quipt Home Medical shares are owned by company insiders. Comparatively, 8.5% of Oncology Institute shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Quipt Home Medical has a net margin of -4.30% compared to Oncology Institute's net margin of -14.26%. Quipt Home Medical's return on equity of -9.78% beat Oncology Institute's return on equity.

Company Net Margins Return on Equity Return on Assets
Quipt Home Medical-4.30% -9.78% -4.23%
Oncology Institute -14.26%-1,527.21%-34.25%

Quipt Home Medical presently has a consensus target price of $3.15, indicating a potential upside of 46.51%. Oncology Institute has a consensus target price of $7.00, indicating a potential upside of 84.70%. Given Oncology Institute's stronger consensus rating and higher possible upside, analysts plainly believe Oncology Institute is more favorable than Quipt Home Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quipt Home Medical
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Oncology Institute
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

Quipt Home Medical has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500. Comparatively, Oncology Institute has a beta of 0.08, meaning that its share price is 92% less volatile than the S&P 500.

In the previous week, Quipt Home Medical had 8 more articles in the media than Oncology Institute. MarketBeat recorded 11 mentions for Quipt Home Medical and 3 mentions for Oncology Institute. Quipt Home Medical's average media sentiment score of 0.98 beat Oncology Institute's score of 0.88 indicating that Quipt Home Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Quipt Home Medical
3 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Oncology Institute
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Quipt Home Medical has higher earnings, but lower revenue than Oncology Institute. Quipt Home Medical is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quipt Home Medical$245.91M0.38-$6.76M-$0.24-8.96
Oncology Institute$393.41M0.86-$64.66M-$0.68-5.57

Summary

Quipt Home Medical beats Oncology Institute on 10 of the 17 factors compared between the two stocks.

Get Quipt Home Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for QIPT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QIPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QIPT vs. The Competition

MetricQuipt Home MedicalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$92.10M$10.84B$5.76B$9.58B
Dividend YieldN/A1.87%4.41%4.10%
P/E Ratio-8.9620.9031.1026.05
Price / Sales0.3829.66435.79105.95
Price / Cash2.0924.5537.7358.48
Price / Book0.913.519.536.61
Net Income-$6.76M$211.77M$3.26B$265.56M
7 Day Performance5.39%4.44%2.09%1.97%
1 Month Performance-4.02%8.85%2.81%-0.36%
1 Year Performance-24.83%-9.03%30.56%19.03%

Quipt Home Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QIPT
Quipt Home Medical
3.3543 of 5 stars
$2.15
+1.4%
$3.15
+46.5%
-21.8%$92.10M$245.91M-8.961,200Analyst Forecast
TOI
Oncology Institute
2.8805 of 5 stars
$4.04
+7.4%
$7.00
+73.3%
+996.0%$335.52M$393.41M-5.94660Short Interest ↓
LFMD
LifeMD
2.6501 of 5 stars
$6.51
+1.2%
$12.86
+97.5%
+25.1%$304.89M$212.45M-31.00230
VMD
Viemed Healthcare
2.0993 of 5 stars
$6.92
+0.4%
N/A+1.2%$267.23M$224.26M20.351,179Positive News
XGN
Exagen
3.7563 of 5 stars
$9.75
+2.7%
$11.25
+15.4%
+231.1%$208.82M$55.64M-10.96220Short Interest ↑
DCGO
DocGo
2.1504 of 5 stars
$1.68
+3.7%
$3.56
+111.9%
-50.3%$158.45M$616.55M-8.844,407Analyst Forecast
CORBF
Global Cord Blood
N/A$1.25
+127.3%
N/A+53.5%$151.94M$196.12M0.001,200
NAKA
KindlyMD
N/A$12.02
-12.1%
N/AN/A$103.17M$2.72M-13.98N/ANews Coverage
Gap Down
EUDA
EUDA Health
N/A$2.64
+3.9%
N/A-43.8%$94.38M$4.01M0.002Gap Up
SERA
Sera Prognostics
1.0914 of 5 stars
$2.38
+5.8%
N/A-66.3%$84.76M$80K-2.80120News Coverage
Positive News
KDLY
Kindly MD
N/A$13.67
-9.0%
N/A+525.3%$82.32M$2.47M-17.75N/APositive News

Related Companies and Tools


This page (NASDAQ:QIPT) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners